Daily Archives: October 1, 2019

Powerful Mining Rigs offer extended by BitHarp

WELLINGTON, New Zealand, Oct. 01, 2019 (GLOBE NEWSWIRE) — BitHarp is pleased to announce an extension of its highly successful ‘3 Plus 1 Offer’ for the company’s profitable mining rigs. Introduced just a couple of weeks ago, this special promotion has been a great success amongst all types of crypto mining enthusiasts.…

Ethan Allen Launches New Membership Program

Danbury, CT, Oct. 01, 2019 (GLOBE NEWSWIRE) — Ethan Allen, a leading global interior design company and a renowned manufacturer and retailer of quality home furnishings, announced the launch of a new Member Program that will enhance the customer experience and provide special members-only everyday savings and benefits.

Sabin Vaccine Institute Receives $20.5 Million From BARDA With Potential of up to $128 Million to Develop Ebola Sudan and Marburg Vaccines

WASHINGTON, Oct. 01, 2019 (GLOBE NEWSWIRE) — The Sabin Vaccine Institute (Sabin) today announced a funding award of $20.5 million with options for an additional $107.5 million from the Biomedical Advanced Research and Development Authority (BARDA) within the U.S.…

Sigma Lithium Announces a Positive Feasibility Study with Forecast LOM Net Revenue of US$1.4 Billion and EBITDA of US$ 690 Million for the High-Grade, Low-Cost Xuxa Deposit

Figure 1

General Site Plan

Positive results confirm an after tax NPV of US$ 249 million with cash operating costs for the Xuxa deposit of US$238 per tonne of battery grade 6% lithium oxide concentrate, amongst the lowest costs globally

The positive economics of the bankable Feasibility Study for Xuxa provide a strong platform for Sigma to continue to develop its extensive mineral properties,  which include 9 past-producing lithium mines

___________________________________

Sigma will host an investor call on October 7th, 2019 at 11:30 a.m.

GMAT™ Official Advanced Questions Now Available

Hard questions taken directly from past GMAT exams, expanding candidate test day preparation options

RESTON, Va., Oct. 01, 2019 (GLOBE NEWSWIRE) — The Graduate Management Admission Council™ (GMAC™), administrator of the Graduate Management Admission Test™ (GMAT™) and a global association of leading graduate business schools, announced today the release of its GMAT™ Official Advanced Questions, the only test preparation material to exclusively contain hard questions from past GMAT exams.

Ctrip Chairman Meets with Philippine Secretary of Tourism

Philippines Tourism to Receive Boost from Ctrip

Ctrip Chairman Meets with Philippine Secretary of Tourism

Ctrip Chairman James Liang (left) meets with Philippines Secretary of Tourism Romulo-Puyat (right)

MANILA, Oct. 01, 2019 (GLOBE NEWSWIRE) — Ctrip Co-founder and Executive Chairman James Liang today met with Philippines Secretary of Tourism Bernadette Romulo-Puyat.…

Third-party evaluation confirms safety profile of Philips Stellarex .035″ low-dose drug-coated balloon

October 1, 2019 

  • Primary safety analysis of Stellarex drug-coated balloon (DCB) three-year data, comprising the largest published, pooled set of randomized controlled trial (RCT) data for a single paclitaxel-based device, shows no difference in mortality between patients treated with the Philips Stellarex DCB and those treated with percutaneous angioplasty, the current standard of care
  • Findings also identified no device-related deaths and no correlation of Stellarex DCB to late all-cause mortality
  • The analyses represent one of industry’s most extensive and rigorous safety assessments of a paclitaxel-based device, and were published in Circulation, a peer-reviewed journal of the American Heart Association

Amsterdam, the Netherlands Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the results of third-party analyses of patient-level data from worldwide clinical trials of the Philips Stellarex .035″ low-dose DCB.